Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags United Parcel Service Inc General Electric Co MSCI Inc
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Business News Biotechnology Business
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Bank of America Corp Tesla Inc Technology
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Eisai Co Ltd Companies Health & Science
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags U/S/ Economy Biotech and Pharmaceuticals Social issues
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Health care industry Companies Eisai Co Ltd
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Markets stocks Market Insider
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Business Alibaba Group Holding Ltd Tesla Inc
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Asia Markets Biogen Inc Pharmaceuticals
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Science Breaking News: Business Business
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Economy Norwegian Cruise Line Holdings Ltd Stock markets
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Biogen Inc US: News US Economy
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Business News Alzheimer's disease Policy
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Oil and Gas Business Food and Beverage
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Eli Lilly and Co US: News Biogen Inc
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Stock markets Breaking News: Markets Economy
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Pandemics Policy Business News
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Quest Diagnostics Inc Epidemics Biotech and Pharmaceuticals
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Biotech and Pharmaceuticals Social issues U/S/ Economy
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Business Biotechnology Science
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Science Breaking News: Business Biotechnology
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Biotech and Pharmaceuticals Breaking news Breaking News: Business
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Breaking news Biotech and Pharmaceuticals Science
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Breaking news US: News Pharmaceuticals
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Breaking news Biotech and Pharmaceuticals Business News
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Business News Policy Pandemics
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Breaking News: Business Biotechnology US Top News and Analysis
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags U/S/ Economy Biotech and Pharmaceuticals Epidemics
From CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Tags Markets stocks Market Insider
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags US: News Biogen Inc Eisai Co Ltd
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.